4.7 Article

Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

Contact tracing as a measure to combat COVID-19 and other infectious diseases

Marvin Du

Summary: Contact tracing plays an important role in mitigating the transmission of COVID-19 and other infectious diseases, especially in a small-world network. Simulation results demonstrate that contact tracing can effectively reduce and delay the peak of daily new cases, particularly by testing asymptomatic and presymptomatic individuals.

AMERICAN JOURNAL OF INFECTION CONTROL (2022)

Article Biochemistry & Molecular Biology

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor

Cecylia S. Lupala et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 virus has resulted in over 270 million infections and 5.3 million deaths worldwide. The emergence of the Omicron variant has raised concerns about reducing vaccine efficacy and neutralizing antibodies due to its numerous mutations. Analysis indicates that the Omicron variant binds more strongly to the human ACE2 protein, with mutations at the ACE2-RBD interface enhancing tight binding through increased hydrogen bonding interactions and enlarged buried solvent accessible surface area.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Immunology

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies

Saathvik R. Kannan et al.

Summary: The Omicron variant of concern (VOC) has a large number of mutations, with 46 high prevalence mutations, which may affect the binding affinities of antibodies to the S protein.

JOURNAL OF AUTOIMMUNITY (2022)

News Item Multidisciplinary Sciences

DELTACRON: THE STORY OF THE VARIANT THAT WASN'T

Freda Kreier

NATURE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

Md Mohiuddin et al.

Summary: The COVID-19 pandemic has strained healthcare systems worldwide, and the emergence of the Omicron variant poses a high global risk of increased infections. Therefore, it is crucial to study and identify effective therapies for this variant.

RESPIRATORY MEDICINE (2022)

Review Environmental Sciences

Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets- Magnifying global pandemic grieve and catastrophe begins

Karthika Pushparaj et al.

Summary: After the COVID-19 pandemic, mucormycosis has become a major concern globally, especially in Asian countries. Uncontrolled diabetes, comorbidities, and immunosuppression from steroid therapy are the main predisposing factors for infection. The number of cases is increasing exponentially in India and other global countries.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Article Immunology

A CRISPR/Cas12a-based DNAzyme visualization system for rapid, non-electrically dependent detection of Bacillus anthracis

Dongshu Wang et al.

Summary: In this study, a complete detection system for Bacillus anthracis based on Cas12a was developed. The system can detect the bacteria with high accuracy in 90 minutes and has single-copy level sensitivity. Additionally, a visualization system for field-based point-of-care detection was created, showing promising prospects.

EMERGING MICROBES & INFECTIONS (2022)

Editorial Material Infectious Diseases

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

Stephen Y. Wang et al.

LANCET MICROBE (2022)

Editorial Material Infectious Diseases

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines

Ramachandra Thiruvengadamt et al.

LANCET INFECTIOUS DISEASES (2022)

Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

Article Multidisciplinary Sciences

Omicron overpowers key COVID antibody treatments in early tests

Max Kozlov

NATURE (2021)

News Item Multidisciplinary Sciences

OMICRON LIKELY TO WEAKEN COVID VACCINE PROTECTION

Ewen Callaway

NATURE (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet et al.

LANCET (2021)

News Item Medicine, General & Internal

Covid 19: US cases rise amid omicron fears but booster shots offer protection, experts say

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2021)

Editorial Material Medicine, General & Internal

Preparing for Omicron as a covid veteran

Eric Kutscher

BMJ-BRITISH MEDICAL JOURNAL (2021)

News Item Medicine, General & Internal

Covid-19: Early studies give hope omicron is milder than other variants

Bryan Christie

BMJ-BRITISH MEDICAL JOURNAL (2021)

Editorial Material Medicine, General & Internal

Omicron: a failure to act with a global focus will continue the proliferation of new variants of covid-19

Maggie Rae

BMJ-BRITISH MEDICAL JOURNAL (2021)

News Item Medicine, General & Internal

Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Infectious Diseases

Novel SARS-CoV-2 variants: the pandemics within the pandemic

Erik Boehm et al.

Summary: Many new variants of SARS-CoV-2 have been identified as variants of concern/interest due to increased transmissibility, severity, immune escape, and reduced vaccine efficacy. These variants often share similar mutations, such as N501Y and E484K, which lead to partial immune escape, decreased vaccine efficacy, and potentially increased severity.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Immunology

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Dandan Tian et al.

Summary: The Delta variant of the SARS-CoV-2 virus, first reported in India in October 2020 and classified as a variant of concern by the WHO in May 2021, is highly transmissible and associated with increased hospitalization, ICU admission, and mortality rates. It has become the dominant strain in many countries globally.

FRONTIERS IN IMMUNOLOGY (2021)

Letter Biochemistry & Molecular Biology

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance

Xiantao Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

The challenges of COVID-19 Delta variant: Prevention and vaccine development

Xuemei He et al.

Summary: The text discusses the emergence of the Delta variant of SARS-CoV-2, highlighting its rapid spread and impact on vaccine effectiveness. It emphasizes the importance of understanding the characteristics and effects of this variant for effective prevention and control measures against COVID-19.

MEDCOMM (2021)

Letter Medicine, General & Internal

COVID-19, WHO guidelines, pedagogy, and respite

Ranjan K. Mohapatra et al.

OPEN MEDICINE (2021)

Review Microbiology

Coronavirus Disease 2019-COVID-19

Kuldeep Dhama et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Review Biotechnology & Applied Microbiology

COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes

Vijaya Anand Arumugam et al.

JOURNAL OF PURE AND APPLIED MICROBIOLOGY (2020)